Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page
- Check5 days agoChange DetectedThe site revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page now displays the clinical trial record, including its study details, outcome measures, publications, and supporting documents, instead of a 403 error.SummaryDifference100%

- Check19 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0. The study record remains inaccessible and displays a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedA general NIH website-transition notice appears above the ClinicalTrials.gov page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating access is blocked. This reflects a permission or access issue rather than a change in the underlying study data.SummaryDifference0.5%

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.